Synthetic Biology Facilitates Semisynthetic Development of Type V Glycopeptide Antibiotics Targeting Vancomycin-Resistant Enterococcus

[Image: see text] The continued efficacy of glycopeptide antibiotics (GPAs) against Gram-positive bacteria is challenged by the emergence and spread of GPA-resistant pathogens, particularly vancomycin-resistant enterococci (VRE). The growing frequency of GPA resistance propels the need for innovativ...

Descripción completa

Detalles Bibliográficos
Autores principales: Koteva, Kalinka, Xu, Min, Wang, Wenliang, Fiebig-Comyn, Aline A., Cook, Michael A., Coombes, Brian K., Wright, Gerard D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350919/
https://www.ncbi.nlm.nih.gov/pubmed/37315221
http://dx.doi.org/10.1021/acs.jmedchem.3c00633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350919/
https://www.ncbi.nlm.nih.gov/pubmed/37315221
http://dx.doi.org/10.1021/acs.jmedchem.3c00633

Ejemplares similares